Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Proven track records create a winning formula for injured workers’ recoveries
The more we work with those who get hurt on the job and the more we study the best outcomes for what went right, it’s clear that effective, high-quality medical care plays an essential role.
New York State Workers' Compensation Board Announces Implementation Delay
The original go-live date of June 7, 2021, has been delayed.
Knee Injuries: Trends and Advances [Recording]
Knee injuries make up a large percentage of medical insurance and health care claims in the orthopedic field.
The Truth About Mental Health and Claim Costs
Traditionally, the term mental health has been treated as a claims pariah in workers’ comp, as it’s been associated with delaying recovery and send
Transportation and translation: an unlikely but powerful duo
Recently, the Sounding Board sat down with Jim Begg, Vice President of National Accounts for Apricus, to talk about transportation and translation services (T&T). We wanted to know more about these types of offerings, seeing that specialty networks like Apricus frequently manage such requests.
Understanding Mental Health Misconceptions in Workers’ Comp
Hello and welcome to the first of a four-part podcast compliment to the Mitchell | Genex | Coventry thought leadership eBook, Strategies for Co